Meticillin-resistant Staphylococcus aureus in Norway, a low-incidence country, 2006-2010

Journal of Hospital Infection

Volumn 80, Issue 1, 2012, Pages 36-40

  Elstrom P ^a   Kacelnik, O ^a   Bruun, T ^a   Iversen, B ^a   Hauge, S H ^a   Aavitsland, P ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Antibiotic resistance; Epidemiology; Infection control; Meticillin resistant Staphylococcus aureus; Surveillance

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL INFECTION; CEREBROSPINAL FLUID ANALYSIS; CHILD; COMMUNITY; DISEASE SEVERITY; EPIDEMIC; EPIDEMIOLOGY; FEMALE; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NORWAY; NURSING HOME; SKIN ABSCESS; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; NORWAY; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84455202350     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.10.004     Document Type: Article

References (21)

1. Annual Epidemiological Report on Communicable Diseases in Europe 2010 2010, European Centre for Disease Prevention and Control, ECDC, Stockholm.
2. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 1998, 339:520-532.
3. Athanassa Z., Siempos I.I., Falagas M.E. Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review. Eur Respir J 2008, 31:625-632.
4. Kang C.I., Song J.H., Chung D.R., et al. Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort. J Infect 2010, 61:299-306.
5. Anderson D.J., Kaye K.S., Chen L.F., et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS ONE 2009, 4:e8305.
6. Cosgrove S.E., Qi Y., Kaye K.S., Harbarth S., Karchmer A.W., Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005, 26:166-174.
7. European Centre for Disease Prevention and Control, European Medicines Agency. ECDC/EMEA Joint Technical Report. The bacterial challenge: time to react. Stockholm: European Centre for Disease Prevention and Control; 2009.
8. Grundmann H., Aires-de-Sousa M., Boyce J., Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006, 368:874-885.
9. Otter J.A., French G.L. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 2010, 10:227-239.
10. Kalenic S., Cookson B., Gallagher R., et al. Comparison of recommendations in national/regional Guidelines for prevention and control of MRSA in thirteen European countries. Int J Infect Control 2010, 6:i2.
11. NORM/NORM-VET 2010 Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway 2011, Tromsø/Oslo: National Veterinay Institute, University Hospital of North Norway/Norwegian Institute of Public Health.
12. Norwegian MRSA Reference Laboratory. [Annual Report 2010] [Norwegian]. Trondheim: St Olav's University Hospital; 2011.
13. Antimicrobial resistance surveillance in Europe 2009. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2010, European Centre for Disease Prevention and Control, ECDC, Stockholm.
14. Lessa F.C., Mu Y., Davies J., et al. Comparison of incidence of bloodstream infection with methicillin-resistant Staphylococcus aureus between England and United States, 2006-2007. Clin Infect Dis 2010, 51:925-928.
15. Summary points on meticillin resistant Staphylococcus aureus (MRSA) bacteraemia 2011, Health Protection Agency, HPA, London.
16. Elstrom P., Aavitsland P. [Meticillin resistant Staphylococcus aureus in Norway]. [Norwegian]. Tidsskr Nor Laegeforen 2008, 128:2730-2733.
17. David M.Z., Daum R.S. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Reviews 2010, 23:616-687.
18. Kock R., Becker K., Cookson B., et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 2010, 15:19688.
19. Analysis of the baseline survey on the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in holdings with breeding pigs, in the EU, 2008, Part A: MRSA prevalence estimates 2009, European Food Safety Authority, Parma: EFSA.
20. NORM/NORM-VET 2008. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Mikalsen J, Simonsen GS, editors. Tromsø/Oslo: National Veterinary Institute, University Hospital of North Norway/Norwegian Institute of Public Health; 2009.
21. Community-associated methicillin-resistant Staphylococcus aureus in Minnesota. Dis Control Newslett 2004, 32:61-72. Minnesota Department of Health.